Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
Editat de Dominique Heymannen Limba Engleză Hardback – 21 sep 2021
The Third Edition expands on the original overview of bone cancer development (physiology and pathophysiology), with 40% new material. Each chapter has been written by internationally recognized specialists on the bone cancer microenvironment, bone metastases, osteoclast biology in bone cancer, proteomics, bone niche, circulating tumor cells, and clinical trials.
Given the global prevalence of breast and prostate cancers, knowledge of bone biology has become essential for everyone within the medical and cancer research communities. Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside continues to offer the only translational reference to cover all aspects of primary bone cancer and bone metastases. This revision opens the door to myeloma with two short chapters dedicated to this bone-associated disease.
- Covers the broad field of bone sarcomas and bone metastases from basic research to clinical approaches
- Presents comprehensive and translational overview of biological and clinical aspects of bone cancers, discussing pathophysiology from genetic and molecular levels using the most recent evidence
- Provides a common language for cancer researchers, bone biologists, oncologists, and radiologists to discuss bone tumors and how bone cancer metastases affects each major organ system
- Offers insights to research clinicians (oncologists and radiologists) into understanding the molecular basis of bone cancer, leading to more well-informed diagnoses and treatment of tumors and metastases
- Offers insights to bone biologists into how clinical observations and practices can feed back into the research cycle and, therefore, can contribute to the development of more targeted genomic and proteomic assays
Toate formatele și edițiile | Preț | Express |
---|---|---|
Hardback (2) | 758.09 lei 5-7 săpt. | |
ELSEVIER SCIENCE – 28 aug 2014 | 758.09 lei 5-7 săpt. | |
ELSEVIER SCIENCE – 21 sep 2021 | 1175.36 lei 5-7 săpt. | +261.75 lei 6-10 zile |
Preț: 1175.36 lei
Preț vechi: 1487.73 lei
-21% Nou
Puncte Express: 1763
Preț estimativ în valută:
224.92€ • 236.56$ • 187.93£
224.92€ • 236.56$ • 187.93£
Carte tipărită la comandă
Livrare economică 01-15 ianuarie 25
Livrare express 03-07 decembrie pentru 271.74 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128216668
ISBN-10: 0128216662
Pagini: 1078
Ilustrații: 175 illustrations (120 in full color)
Dimensiuni: 216 x 276 x 56 mm
Greutate: 0.45 kg
Ediția:3
Editura: ELSEVIER SCIENCE
ISBN-10: 0128216662
Pagini: 1078
Ilustrații: 175 illustrations (120 in full color)
Dimensiuni: 216 x 276 x 56 mm
Greutate: 0.45 kg
Ediția:3
Editura: ELSEVIER SCIENCE
Cuprins
Epidemiology of Bone Cancer
1. Osteoarchaeology: lessons to learn from the past
2. Epidemiology of primary bone tumors and economical aspects of bone metastases
Models of Bone Cancers and Technical Aspects
Animal Models
3. Animal models of bone sarcomas
4. In vivo models used in studies of bone metastaes
5. Zebrafish models for studying bone tumors
Mathematic models and machine learning
6. Use of machine learning in bone cancers
7. Artifical intelligence for bone cancer imaging
Preparation of tissue samples: technical aspects
8. Technical aspects: how do we best prepare bone samples for proper histological analysis?
Bone Microenvironment and Bone Cancer
Bone niche
9. Bone niche and bone metastases
10. Bone: a fertil soil for tumor development
11. Osteomimicry: old concepts and new findings
Dialog between cancer cells and bone cells
12. Role of mesenchymal stem cells in bone cancers, initiation, propagation and metastasis
13. Technical approaches for studying the communications between osteocytes and cancer cells
14. Osteocytes and bone cancers
15. Immune functions of osteoclasts: new insights for bone cancers
16. Immune infiltrate in bone sarcomas
17. Macrophages and pathophysiology of bone cancers
Mediators of cell communications
18. Growth factors, cytokines and pediatric malignant primary bones tumors
19. The role of NFkB in bone cancer
20. TGF-beta and bone cancers: a specific focus
21. Extracellular vesicles, tumor growth and metastatic process
22. Connexin43 and development of primary bone tumors : osteosarcoma and Ewing’s sarcoma
23. The role of endocannabinoid system in bone cancer
Metabolism
24. Impact of the microenvironment acidosis on bone cancers
25. Hypoxic niche and bone cancers
26. Metabolism and bone cancers
Bone Tumor Heterogeneity, Plasticity and Biomarkers
Heterogeneity and plasticity
27. EMT process in bone metastasis
28. Cancer stem cells and clonal evolution in bone sarcomas
29. Dormancy in cancer bone metastasis
Biomarkers
30. Bone Remodelling Markers and Bone Cancer
31. Epigenetic Heterogeneity in Primary Bone Cancers
32. miRNA implication in therapeutic resistance and metastatic dissemination of bone-associated tumors
33. MicroRNAs and bone metastasis: how small RNAs regulate secondary tumour formation and progression in the skeleton
34. Long-non coding RNA and bone sarcoma
35. Liquid biopsy and circulating tumor cells in bone sarcomas: identification of new biomarkers and analysis of the tumor heterogeneity
36. Disseminated tumor cells in bone marrow of cancer patients
II. PRIMARY BONE TUMORS
Biological aspects
37. Cytogenetics of bone sarcomas
38. Genetic aspects of primary bone tumors
39. Markers of bone sarcomas
40. Molecular pathology of osteosarcoma
41. Genomic and proteomic profiling of osteosarcoma
42. Ewing sarcoma family of tumors
43. Molecular aspects of Ewing sarcomas
44. Osteoclast-rich lesions: a clinical and molecular overview
45. Biology of cartilage tumor family
Clinical aspects and Perspectives
Imaging
46. Imaging of bone sarcomas
Therapeutic approaches
47. Current therapeutic approaches of bone sarcomas
48. Surgical approaches of bone sarcomas: Margins and clinical impact
49. Apoptosis and drug resistance in malignant bone tumors: impact on the clinical practices
50. Chondrosarcoma of Bone: Diagnosis and Therapy
51. Radiotherapy and Primary bone tumors
52. New therapeutic advances of bone sarcomas
III. BONE METASTASES
Biological aspects
53. The histopathology of skeletal Metastases
54. Indentification of new therapeutic targets of bone cancers by proteomic strategies
Clinical aspects and Perspectives
Imaging
55. Interventional radiologic techniques in management of bone tumors
56. Diagnosis of bone metastases in urological malignancies – an update
Bone pain
57. Mechanisms and management of bone cancer pain
58. Involvement of sympathic nerves in bone mestastasis
59. Pain control with palliative radiotherapy in patients with bone metastases
60. Palliative care of bone metastases
Therapeutic approaches
61. Radiotherapy of bone metastases
62. Cellular and molecular actions of bisphosphonates: therapeutic interest in tumor-associated bone diseases
63. Bone-Targeted agents and skeletal-related events in breast cancer patients with bone metastases
64. Bone metastases – current status of bone-targeted treatments
65. Therapies of bone metastases in castration-resistant prostate cancer
66. Therapy with bone-targeting radiopharmaceuticals
67. Therapeutic approaches of bone metastases associated with breast cancer
MYELOMA: A BONE ASSOCIATED DISEASE
68. Biological relationship between bone and myeloma cells
69. Recent therapeutic approaches in myeloma
1. Osteoarchaeology: lessons to learn from the past
2. Epidemiology of primary bone tumors and economical aspects of bone metastases
Models of Bone Cancers and Technical Aspects
Animal Models
3. Animal models of bone sarcomas
4. In vivo models used in studies of bone metastaes
5. Zebrafish models for studying bone tumors
Mathematic models and machine learning
6. Use of machine learning in bone cancers
7. Artifical intelligence for bone cancer imaging
Preparation of tissue samples: technical aspects
8. Technical aspects: how do we best prepare bone samples for proper histological analysis?
Bone Microenvironment and Bone Cancer
Bone niche
9. Bone niche and bone metastases
10. Bone: a fertil soil for tumor development
11. Osteomimicry: old concepts and new findings
Dialog between cancer cells and bone cells
12. Role of mesenchymal stem cells in bone cancers, initiation, propagation and metastasis
13. Technical approaches for studying the communications between osteocytes and cancer cells
14. Osteocytes and bone cancers
15. Immune functions of osteoclasts: new insights for bone cancers
16. Immune infiltrate in bone sarcomas
17. Macrophages and pathophysiology of bone cancers
Mediators of cell communications
18. Growth factors, cytokines and pediatric malignant primary bones tumors
19. The role of NFkB in bone cancer
20. TGF-beta and bone cancers: a specific focus
21. Extracellular vesicles, tumor growth and metastatic process
22. Connexin43 and development of primary bone tumors : osteosarcoma and Ewing’s sarcoma
23. The role of endocannabinoid system in bone cancer
Metabolism
24. Impact of the microenvironment acidosis on bone cancers
25. Hypoxic niche and bone cancers
26. Metabolism and bone cancers
Bone Tumor Heterogeneity, Plasticity and Biomarkers
Heterogeneity and plasticity
27. EMT process in bone metastasis
28. Cancer stem cells and clonal evolution in bone sarcomas
29. Dormancy in cancer bone metastasis
Biomarkers
30. Bone Remodelling Markers and Bone Cancer
31. Epigenetic Heterogeneity in Primary Bone Cancers
32. miRNA implication in therapeutic resistance and metastatic dissemination of bone-associated tumors
33. MicroRNAs and bone metastasis: how small RNAs regulate secondary tumour formation and progression in the skeleton
34. Long-non coding RNA and bone sarcoma
35. Liquid biopsy and circulating tumor cells in bone sarcomas: identification of new biomarkers and analysis of the tumor heterogeneity
36. Disseminated tumor cells in bone marrow of cancer patients
II. PRIMARY BONE TUMORS
Biological aspects
37. Cytogenetics of bone sarcomas
38. Genetic aspects of primary bone tumors
39. Markers of bone sarcomas
40. Molecular pathology of osteosarcoma
41. Genomic and proteomic profiling of osteosarcoma
42. Ewing sarcoma family of tumors
43. Molecular aspects of Ewing sarcomas
44. Osteoclast-rich lesions: a clinical and molecular overview
45. Biology of cartilage tumor family
Clinical aspects and Perspectives
Imaging
46. Imaging of bone sarcomas
Therapeutic approaches
47. Current therapeutic approaches of bone sarcomas
48. Surgical approaches of bone sarcomas: Margins and clinical impact
49. Apoptosis and drug resistance in malignant bone tumors: impact on the clinical practices
50. Chondrosarcoma of Bone: Diagnosis and Therapy
51. Radiotherapy and Primary bone tumors
52. New therapeutic advances of bone sarcomas
III. BONE METASTASES
Biological aspects
53. The histopathology of skeletal Metastases
54. Indentification of new therapeutic targets of bone cancers by proteomic strategies
Clinical aspects and Perspectives
Imaging
55. Interventional radiologic techniques in management of bone tumors
56. Diagnosis of bone metastases in urological malignancies – an update
Bone pain
57. Mechanisms and management of bone cancer pain
58. Involvement of sympathic nerves in bone mestastasis
59. Pain control with palliative radiotherapy in patients with bone metastases
60. Palliative care of bone metastases
Therapeutic approaches
61. Radiotherapy of bone metastases
62. Cellular and molecular actions of bisphosphonates: therapeutic interest in tumor-associated bone diseases
63. Bone-Targeted agents and skeletal-related events in breast cancer patients with bone metastases
64. Bone metastases – current status of bone-targeted treatments
65. Therapies of bone metastases in castration-resistant prostate cancer
66. Therapy with bone-targeting radiopharmaceuticals
67. Therapeutic approaches of bone metastases associated with breast cancer
MYELOMA: A BONE ASSOCIATED DISEASE
68. Biological relationship between bone and myeloma cells
69. Recent therapeutic approaches in myeloma
Recenzii
Praise for the Previous Editions: "...a comprehensive description of bone tumors from basic to clinical aspects by the most recent data available...specifically useful to medical students and scientists, health professionals, researchers and teachers working in the osteo-articular field." --Anticancer Research
"Reviewing the current advances in the progression and therapeutic approaches to bone cancer is an extremely challenging task. Bone cancer is not a single disease; rather, it is a field comprising a diverse and complex range of malignancies, from primary bone tumors of stromal cell origin, to hematopoietic malignancies and secondary metastatic bone disease. Dominique Heymann has assembled an exciting, comprehensive and up-to-date series of reviews contributed by experts in the basic and clinical aspects of bone research. In the past decade, our understanding of cancers involving bone has increased tremendously, underpinned by advances in the cellular, molecular and biochemical mechanisms of bone cell interactions in health and disease, together with advances in genetics, diagnostics, imaging and therapeutic strategies. All these aspects are covered in this timely volume, which will galvanize further cooperative efforts in the coming years between basic researchers, oncologists and pathologists towards understanding the causes of different bone cancers and translating this knowledge into the clinic." --Agi E. Grigoriadis, PhD, Departments of Craniofacial Development and Orthodontics, King's College London, United Kingdom
"Our understanding of bone biology and diseases has strikingly progressed in the last decade. In parallel, the processes that lead to various forms of cancer have been further unraveled and the mechanisms leading to metastatic spread further explored. In this book, Dr. Heymann has gathered some of the world experts on these subjects to explore the cutting edge where these fields merge in the context of bone cancer and metastasis, their pathophysiology, diagnosis and treatment. This encompassing book will undoubtedly meet the needs of residents and fellows as well as expert clinicians and scientists." --Roland Baron, Professor, Harvard Medical School, Boston MA, USA
"Reviewing the current advances in the progression and therapeutic approaches to bone cancer is an extremely challenging task. Bone cancer is not a single disease; rather, it is a field comprising a diverse and complex range of malignancies, from primary bone tumors of stromal cell origin, to hematopoietic malignancies and secondary metastatic bone disease. Dominique Heymann has assembled an exciting, comprehensive and up-to-date series of reviews contributed by experts in the basic and clinical aspects of bone research. In the past decade, our understanding of cancers involving bone has increased tremendously, underpinned by advances in the cellular, molecular and biochemical mechanisms of bone cell interactions in health and disease, together with advances in genetics, diagnostics, imaging and therapeutic strategies. All these aspects are covered in this timely volume, which will galvanize further cooperative efforts in the coming years between basic researchers, oncologists and pathologists towards understanding the causes of different bone cancers and translating this knowledge into the clinic." --Agi E. Grigoriadis, PhD, Departments of Craniofacial Development and Orthodontics, King's College London, United Kingdom
"Our understanding of bone biology and diseases has strikingly progressed in the last decade. In parallel, the processes that lead to various forms of cancer have been further unraveled and the mechanisms leading to metastatic spread further explored. In this book, Dr. Heymann has gathered some of the world experts on these subjects to explore the cutting edge where these fields merge in the context of bone cancer and metastasis, their pathophysiology, diagnosis and treatment. This encompassing book will undoubtedly meet the needs of residents and fellows as well as expert clinicians and scientists." --Roland Baron, Professor, Harvard Medical School, Boston MA, USA